Patents by Inventor Hansjoerg LEHMANN

Hansjoerg LEHMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted quinazolin-4-one derivatives
    Patent number: 9840498
    Abstract: Provided are substituted quinazolin-4-one compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein R1, R2, R3, R5, R6 and L are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the class I PI3K kinases.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: December 12, 2017
    Assignee: Novartis AG
    Inventors: Zhenxing Du, Samuel Hintermann, Konstanze Hurth, Sébastien Jacquier, Hansjoerg Lehmann, Henrik Moebitz, Nicolas Soldermann, Aleksandar Stojanovic
  • Substituted Quinazolin-4-one Derivatives
    Publication number: 20160168131
    Abstract: Provided are substituted quinazolin-4-one compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein R1, R2, R3, R5, R6 and L are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the class I PI3K kinases.
    Type: Application
    Filed: July 24, 2014
    Publication date: June 16, 2016
    Applicant: NOVARTIS AG
    Inventors: Zhenxing DU, Samuel HINTERMANN, Konstanze HURTH, Sébastien JACQUIER, Hansjoerg LEHMANN, Henrik MOEBITZ, Nicolas SOLDERMANN, Aleksandar STOJANOVIC